December 9, 2021
This blog series is a place for the ALS community to learn about and stay updated on ALS Canada’s advocacy efforts as well as relevant developments within government. Please note that because ALS Canada advocates federally and provincially within Ontario,... Read More
December 8, 2021
Steve Daly loved to belt out a tune for family and friends. The 50-year-old husband and father of four is known for his extroverted personality and, before being diagnosed with ALS, enjoyed playing hockey, riding road bikes with friends, cooking... Read More
December 6, 2021
“ALS doesn’t stop. Neither will we.” ALS researcher and ALS Canada Board Member Christine Vande Velde said these words at the start of the pandemic in reference to her team’s work in the lab, but they were quickly adopted as... Read More
November 22, 2021
Toronto, ON – The in-home support that the ALS Society of Canada provides to people living with ALS is highly valued by the community it serves and is something it had to evolve after the pandemic made physical distancing a... Read More
November 10, 2021
Update: July 7, 2022: Following Health Canada's approval of ALBRIOZA (AMX0035) under a Notice of Compliance with Conditions (NOC/c), CADTH posted reimbursement recommendations for ALBRIOZA (AMX0035) in late June. ALS Canada provided feedback on the recommendations, bringing forward the perspectives... Read More
Clinical trial evaluates the drug enoxacin as a therapeutic option for ALS, add-on studies supported by Discovery Grant
November 4, 2021
An international Canada-Israel research partnership is taking important steps to determine whether a known drug has the potential to become a viable treatment for people with ALS. Recently, using a mouse model, Dr. Eran Hornstein of the Weizmann Institute of... Read More
